Overview
Michael Styler is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Styler is rated as an Experienced provider by MediFind in the treatment of Purpura. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Multiple Myeloma, Colorectal Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3401 N Broad St, Philadelphia, PA 19140
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Penn-Medical Group
Vivek Upadhyay is a Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Upadhyay is rated as an Advanced provider by MediFind in the treatment of Purpura. His top areas of expertise are Purpura, Thrombocytopenia, Acute Myeloid Leukemia (AML), Febrile Neutropenia, and Bone Marrow Aspiration.
Farzana Sayani is a Hematologist and a Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Sayani is rated as a Distinguished provider by MediFind in the treatment of Purpura. Her top areas of expertise are Sickle Cell Disease, Thalassemia, Beta Thalassemia, and Hemoglobin SC Disease.
Peter Pickens is a Hematologist Oncology specialist and a Hematologist in Meadowbrook, Pennsylvania. Dr. Pickens is rated as an Advanced provider by MediFind in the treatment of Purpura. His top areas of expertise are Pleuropulmonary Blastoma, Classical Hodgkin Lymphoma, Iron Deficiency Anemia, Hodgkin Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Dr. Styler isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Colorectal CancerDr. Styler isDistinguished. Learn about Colorectal Cancer.
- Multiple MyelomaDr. Styler isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Styler isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Styler isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Styler isAdvanced. Learn about Anemia.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Styler isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Styler isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Styler isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Styler isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Styler isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anaplastic Large Cell LymphomaDr. Styler isExperienced. Learn about Anaplastic Large Cell Lymphoma.